INTEGRILIN

LOE ApproachingPeptide

eptifibatide

NDAINJECTIONINJECTABLEPriority Review
Approved
May 1998
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
5

Clinical Trials (5)

NCT01919723Phase 2Completed

Ticagrelor and Eptifibatide Bolus-Only Versus Ticagrelor and Eptifibatide Bolus Plus Abbreviated Infusion

Started Feb 2014
70 enrolled
Acute Coronary Syndrome
NCT01522417Phase 2Completed

Shortened Aggrastat® Versus Integrilin in Percutaneous Coronary Intervention

Started Apr 2012
535 enrolled
Myocardial InfarctionAcute Coronary SyndromesUnstable Angina
NCT01076764Phase 3Completed

Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy

Started Apr 2010
13,220 enrolled
Acute Coronary Syndrome
NCT00426751Phase 3Completed

Efficacy Of Eptifibatide Compared To Abciximab In Primary Percutaneous Coronary Intervention (PCI) For Acute ST Elevation Myocardial Infarction (STEMI)

Started Oct 2006
429 enrolled
Infarction, Myocardial
NCT00317395Phase 2Completed

Study of Otamixaban Versus Unfractionated Heparin (UFH) and Eptifibatide in Non-ST Elevation Acute Coronary Syndrome

Started Jun 2006
3,241 enrolled
Coronary Disease